Setting new standards in information exchange for the pharmaceutical and biotech industry
Coming up on DPharm 2012!
July 27, 2012
Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly just joined the Disruptive Innovations speaking faculty where he will provide an opening address on:
Disruptive Innovation: Moving Beyond the Talk
- A case for action to move beyond incremental improvement
- Concrete opportunities for disruptive innovation in clinical development
- Are you on board? The tide is rising.